Delivery Order SPE2DB22D3401-SPE2DB25FT6HC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,367.56 to AmerisourceBergen Drug Corp for QUVIVIQ 25 mg tablets (30-count supply) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the vendor's established pharmaceutical supply relationship with the federal government. The product will be delivered to the place of performance in...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,611.45 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Quviviq 25 mg tablets (30-count). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and requires completion by September 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical federal medical procurement vendor, particularly supporting...
- The Defense Logistics Agency awarded a $369,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50mg QUVIVIQ tablets. The order is for 30 units of the medication to be delivered to a location in Conshohocken, Pennsylvania by August 28, 2023. Amerisourcebergen will serve as the prime contractor to fulfill this order placed under an unspecified multiple award contract vehicle by the DOD agency. No set aside designation or subcontractors are indicated. This award...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,528.80, is for the delivery of QUVIVIQ 50 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen Drug Corp is a large, for-profit pharmaceutical distribution company that plays a critical role in supplying medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of QUVIVIQ 25 MG TABLET 30S. The contract has a firm fixed price of $1,027.28 and a performance period through June 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- This is a $1,264.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QUVIVIQ 50 MG TABLET 30S, a pharmaceutical product, with a performance period ending on March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,481.60 and is for the delivery of QUVIVIQ 50 MG TABLET 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of March 13, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- The Defense Logistics Agency awarded a $780 delivery order to Amerisourcebergen Drug Corporation for 4562030412 QUVIVIQ 50 MG TABLET 30S. The firm fixed price order is being fulfilled under an existing Prime Vendor Pharmaceutical contract vehicle and will provide the Defense Logistics Agency with the specified pharmaceutical product. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from September 1st through September 5th, 2023....
- The Defense Logistics Agency Troop Support Medical awarded a $123,140 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561696953 QUVIVIQ 50 MG TABLET 30S. The place of performance is Conshohocken, Pennsylvania. The period of performance is August 3, 2023 through August 4, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite-delivery/indefinite-quantity contract vehicle....
- The Defense Logistics Agency awarded a $246,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561543638 QUVIVIQ 50 MG TABLET 30S. The prime contractor, Amerisourcebergen Drug Corporation, is headquartered in Conshohocken, Pennsylvania and will fulfill the order from its facility located at the same address. Funding is provided by DLA to support its medical supply needs. No subcontractors or set aside designations were specified. The single day period of performance...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6HCDelivery Order
The Defense Logistics Agency awarded a $3,846.82 delivery order to AmerisourceBergen Drug Corp for QUVIVIQ 50 mg tablets (30-count) on September 18, 2025, with an ultimate completion date of September 19, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order for QUVIVIQ—an insomnia treatment medication—reflects the company's ongoing role in supporting military medical supply chain requirements through competitively awarded contracts with firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/18/25 |